Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Medulloblastoma
Related studies linked through entity extraction aliases.
Dosimetry Guided PRRT With 90Y-DOTATOC
- Status
- WITHDRAWN
- Phase
- PHASE2
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma
- Status
- COMPLETED
- Phase
- N/A
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Radiation Therapy and Combination Chemotherapy for Medulloblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Molecular-Guided Therapy for Childhood Cancer
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Valproic Acid in Childhood Progressive Brain Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
- Status
- UNKNOWN
- Phase
- PHASE2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
- Status
- COMPLETED
- Phase
- NA